Innovative Research, Inc. Acquires Molecular Innovations, Inc.

Posted by Adam Awdish on

Novi, MI, October 1, 2021 - Innovative Research, Inc. has finalized its agreement to acquire Molecular Innovations, Inc.  “These two companies have been strategic partners for the past twenty years, it only makes sense they merge and improve future collaboration and operations,” says Carl Rosenblum, Director of Customer Support at Innovative Research.  “As we went through this process it became clearer what we were gaining as a total organization by joining Innovative Research,” said Duane Day, President and Owner of Molecular Innovations, Inc.


This combination of resources will allow Innovative Research to leverage the thirty years of high-quality production and expertise in coagulation and thrombolysis while identifying new areas of product development and investment to meet customer need. Headquarters will be maintained in Novi, MI and Innovative Research will continue to provide reliable reagents to clients both domestic and International.

If you have an unfulfilled Molecular Innovations Sales Order, you will be notified with updated information on October 4, 2021. Should your original PO need revised for proper fulfillment, your assistance in doing so is appreciated.  Please direct any inquiries to Carl Rosenblum, 248-896-0145, ext. 102.


Share this post


Related Posts

Case closed? Genetic testing provides insight into unexplained sudden deaths of Amish children
An Amish family suffered a sudden and tragic event when one of their children died sudd...
Read the Article
PAI-1 Mutation in Amish Community Could Lead to New Treatments for Age-Related Disorders
In the early 1990s, a paper was published in the New England Journal of Medicine that d...
Read the Article
The case for PAI-1 as a biomarker for major depressive disorder and antidepressant resistance
If research dollars were allocated according to the extent of human distress, major dep...
Read the Article

← Older Post Newer Post →

×